Abbelight

Develops a liquid biopsy diagnostic technology combining super-resolution microscopy, extracellular vesicles and artificial intelligence. This approach improves the detection and analysis of circulating biomarkers, offering greater precision for the early diagnosis and monitoring of diseases, particularly in oncology. By integrating these advances, the solution optimises precision medicine and opens up new prospects for more targeted and effective treatments.